Skip to content

RAND: Microdosing surges as millions turned to psychedelics in 2025

Valerie A. Canady

Mental Health Weekly January 23, 2026 DOI: 10.1002/mhw.34732 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Survey Peer reviewed
Population U.S. adults
Topics Microdosing
Keywords Internet privacy Computer security
Key findings Millions of U.S. adults now microdose psychedelics, often for goals distinct from traditional full-dose use.

Abstract

Microdosing — once a niche practice whispered about in online forums and tech circles — has firmly entered the mainstream. A new RAND survey suggests that millions of U.S. adults are now taking sub‐perceptual amounts of psychedelics such as psilocybin, LSD and MDMA, often with goals that differ sharply from those associated with traditional, full‐dose use.

Comparable studies

Other cross-sectional and survey studies on microdosing, most cited first.

Study Year Design Participants
Motives and Side-Effects of Microdosing With Psychedelics Among Users Psychedelic users with microdosing experience 2019 Cross-sectional survey n = 1,116
Microdosing psychedelics: Motivations, subjective effects and harm reduction People aged 16 years or older who had used psychedelics and could comprehend written... 2019 Cross-sectional survey n = 525
Psychedelic Microdosing: Prevalence and Subjective Effects Anonymous online survey respondents 2020 Cross-sectional survey n = 2,347
Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers Adults 18 or older diagnosed with at least one mental or physiological disorder by a... 2019 Cross-sectional survey n = 410
Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities Adults recruited primarily from the online forum Reddit 2020 Cross-sectional survey n = 909

Explore topics